Branch Retinal Vein Occlusion

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Branch Retinal Vein Occlusion trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT07205887

A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO

EYE-RES-104 is a randomized, dose-masked study of intravitreal EYE103 in participants with neovascular age-related macular degeneration (NVAMD) or macular edema…

United States160 participantsStarted 2025-09-12

Treatment: EYE103, Aflibercept 2.0 mg

All recent trials (91 shown)

Not Yet RecruitingPhase 4

NCT07240649

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications

This study will evaluate the effectiveness of hyperbaric oxygen therapy (HBOT) on treating emerging indications (i.e., conditions that have shown to potentially…

Location not specified100 participantsStarted 2026-08

Treatment: Hyperbaric oxygen treatment (HBOT), 100% Oxygen

CompletedPhase 2

NCT07550504

A Study to Evaluate the Usability of the SB11 PFS in Trial Participants With Wet AMD, Macular Oedema Secondary to RVO, o…

This is a open label, multicenter, Phase II study to evaluate the usability of the pre-filled syringe (PFS) of SB11 (ranibizumab biosimilar). Healthcare Profess…

Poland30 participantsStarted 2026-03-30

Treatment: SB11 PFS

Branch Retinal Vein Occlusion

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO

All recent trials (91 shown)

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications

A Study to Evaluate the Usability of the SB11 PFS in Trial Participants With Wet AMD, Macular Oedema Secondary to RVO, o…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO

All recent trials (91 shown)

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications

A Study to Evaluate the Usability of the SB11 PFS in Trial Participants With Wet AMD, Macular Oedema Secondary to RVO, o…

A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual Impairment…

A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Following Branch…

A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products

A Phase III Study for 601 Versus Ranibizumab in Patients With Vision Loss

601 Versus Ranibizumab in Patients With Branch Retinal Vein Occlusion (BRVO)

A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders

Ocular Safety and Usability Study for FYB201 PFS

Ocular Safety and Usability Study for FYB203 PFS

Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degenera…

Eylea and Lucentis for Macular Edema in Branch Retinal Vein Occlusion

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal…

A Study to Understand the Usage of an Artificial Intelligence Technology Called DARWEN for Eye Disorders and to Find Out…

A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Ede…

Effect of Avastin in Juxtafoveal Telangiectasias

Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole

Assessment Of Peri-papillary Retinal Nerve Fiber Layer Thickness In Patients With Unilateral Branch Retinal Vein Occlusi…

Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole

A Study to Evaluate an Updated Dexamethasone Intravitreal (Into the Eye) Applicator in Adult Participants With Macular E…